Skip to content
October 25–27, 2027 · Orlando

Scientific sessions

Risk and Benefit of New Therapies

Individualization of care with careful medication selection is increasingly recognized as one of the foundations of care for diabetes, which is not a disease of "one size fits all." The amount of time spent in a condition of hyperglycemia has long been known to raise the risk of complications. Hyperglycemia can leave a negative "metabolic memory" on cells of the vasculature and target organs, encouraging the development of difficulties in the future. Despite the necessity of meeting proper glycemic targets, there is still a gap between the goals specified and the goals achieved. Failure to commence or intensify treatment in a timely manner in persons whose health is expected to improve with this intensification is referred to as clinical inertia

See all scientific sessions at Diabetes 2027 →

Join the Diabetes 2027 delegation

Orlando · October 25–27, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.